Using high-performance thin-layer chromatography, we identified GM1, GM3, GD3, GDla, GTlb, GQlb, and other gangliosides in chinchilla cochlea and cerebellum. GM1 was also identified on chromatograms with the B-subunit ofcholera toxin (BCT). BCT was ?Is0 used to determine the disuibution of GM1 in fmed and d i e d tissues from cochlea, cerebellum, and sciatic nem. Positive control tissues showed expected labeling of GMl by BCT. Negative controls showed expected suppression of BCT binding to GM1 after GMl extraction and GM1 absorption. In the cochlea, GM1 appeared abundant in plasma membranes of most epithelial cells lining the endolymphatic surface of the scala media, including the interdental, inner supporting, pillar, Deiters, Hensen, Claudius, Boettcher, spiral prominence, and external sulcus. GMI appeared less abundant in cells of the stria vascularis, Reissner's membrane, and in netve fibers. In hair * Correspondence to: Dr. Peter Santi, Dept. Otolaryngology, Univ. Minnesota, Rm. 282, Lions Research Bldg., 2001 Sixth St. SE, Minneapolis, MN 55455.
Introduction
Gangliosides are glycolipids containing one or more sialic acid residues, usually of the N-acetyl-neuraminic acid type. Owing to oligosacharide heterogeneity, approximately 90 different gangliosides have been identified (1). Gangliosides usually occur in the outer leaflet of the cell membrane, and in neural tissues; they can comprise 10% of the total lipid ofthe cell membrane (2) . Therefore, they can significantly contribute to the glycocalyx of neural tissues.
Gangliosides serve a wide variety of functions associated with the cell membrane, including modulation of calcium transport (3,4), receptors for glycoprotein hormones (5), cell adhesion (6-9), and neuritogenesis (10) (11) (12) (13) (14) . Administration of exogenous gangliosides
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Supported by grants from the National Institute on Deafness and Communication Disorders (NIDCD), the Deafness Research Foundation, and the Consiglio Nazionale delle Ricerche (CNR) Rome, Italy. provides neuroprotective effects after ischemia (15-17), retrograde degeneration after posterior neocortex lesions (18) , and excitotoxin damage (19) . In hearing, exogenous administration of gangliosides exerts a protective effrt on cochlear microphonics and action potentials after acoustic trauma and experimentally induced diabetes in animals (20,21). Recovery from unilateral vestibular lesion was also facilitated by exogenous ganglioside administration (22) .
Antibodies against GM1 and other gangliosides have been described in several human neurological and autoimmune diseases, such as Guillain-Barre syndrome (23-28) and multiple sclerosis (29, 30) . However, the pathogenic role of these autoantibodies has been questioned (31,32). Auditory and vestibular dysfunctions haw also been reported in patients with Guillain-Barre syndrome (33) and multiple sclerosis (34,35). Antibodies against gangliosides have been produced by immunization of animals with gangliosides (36-40). Antiganglioside antibodies have been shown to produce noxious effects on neural tissues, such as neurocytotoxicity (41) and demyelination in the CNS and PNS (42).
Failure to catabolize gangliosides also appears to be detrimental and is the result of congenital defects collectively known as gangliosidoses. The infantile form GM1 gangliosidosis has been associated with deafness (43). This defixt results in failure to catabolize 705 GM1 and galactose-containing glycoproteins owing to the absence of the degradative enzyme P-galactosidase (43-45). Storage ofGM1 in the brain is approximately 10 times normal levels, and a large number of galactose-containing oligosaccharides are present in the urine of patients with GM1 gangliosidosis (43).
The most extensively investigated ganglioside is GMl, owing to the identifcation and availability of a high-affinity specific binding protein, cholera toxin (46.47). The holotoxin is produced by Vibrio cholerae bacteria and consists of two subunits. The B-subunit forms a ring-shaped pentamer which supports a dimer, the A-subunit. The B-subunit specifically binds up to five GM1 ganglioside molecules. After binding, the A-subunit penetrates the cell membrane, where it irreversibly activates adenylate cyclase (5,48-52). The B-subunit separated from the A-subunit is also called choleragenoid and retains its specific binding activity to GM1 (53,54). The B-subunit combined with fluorescein isothiocyanate (FIK), horseradish peroxidase (HRP), and colloidal gold has been used to localize GMI on the surface of unfixed, fixed, and sectioned cells in a variety of tissues (S5-58) . We have previously reported the distribution of GM1 in the vestibular system using cholera t& probes (59) and have also provided a preliminary description of its distribution in the cochlea (60).
In addition, the presence of GM1 and other gangliosides in rat cochlea has been reported in a biochemical study by Maguchi and coworkers (61). In the present study we report the identification of GM1 and other gangliosides in the cochlea using high-performance thin-layer chromatography (HPTLC) and the histochemical localization of GM1 by the B-subunit of cholera toxin (BCT) coupled with FIE and HRP.
Materials and Methods

Animals
Thirty normal chinchillas approximately 1 year old were cared for and maintained according to NIH guidelines in a facility supervised by University of Minnesota veterinarians. This research protocol was also approved by our Institutional Animal Care Committee. The animals were anesthetized with an IM injection of ketamine (90 mglkg) and an IP injection of sodium pentobarbital (20 mg/kg). After a surgical level of anesthesia was reached, the animals were decapitated and both cochleas were removed and processed for HPTLC and light microscopic histochemistry for the presence of gangliosides. In addition to cochlear tissue, small portions of sciatic nerve and cerebellum were as0 removed and histochemically processed to serve as positive controls.
High-perfomance Thin-layer Chromatography
To biochemically analyze the presence of gangliosides in the cochlea and cerebellum, HPTLC was performed using 10 of the 30 animals. Total lipids were extracted from whole inner ears and small portions ofthe cerebellum in 3 x 2-ml volumes of chloroform-methanol (CM; 22, 1:1, 1:2) using a hand-operated glass homogenizer (62.63). After the third extraction, bone and insoluble tissues were removed by centrifugation for 10 min at 1300 x g and the supernatants were combined and dried under a stream of nitrogen. One inner ear yielded enough gangliosides for three chromatograms.
Gangliosides were reconstituted in 1 ml of CM 2:1 and purified by layering the extract in a 2 cm-long Pasteur pipette column of silicic acid (Sigma; St Louis, MO) on a bed of glass wool and sand (64). The silicic acid column was used to separate neutral from acidic lipids, i.e., gangliosides. Neutral lipids were eluted from the column with 2 ml of CM 2:1. Gangliosides were subsequently eluted using 2 x 1 ml of CM:water (5050:lS). After the second elution, the silicic acid bed was stirred and gentle pressure was applied to the column. The acidic fraction containing the gangliosides was run through a second silicic acid column for further purification. The ganglioside fraction was dried under a nitrogen stream and reconstituted in CM 2:l for spotting on aluminum-backed silica gel 60 HF' TLC plates (10 x 10 un) (Merck Darmstadt, Germany).
Aliquots (10 pl) of purified ganglioside fractions from inner ear, cerebellum, and ganglioside standards (2 bg each of GM3, GM2, GM1, GDla) (Sigma) were spotted on the HPTLC plates in 5 mm-long loading bands using a Hamilton syringe. The plate was developed for 50 min in CM:0.2 % CaC12 (6040:9). After drying for 15 min. gangliosides were visualized by spraying the plate with resorcinol-HC1 reagent (65). The plates were heated in an oven for 30 min at 95'C to reveal the purple-stained ganglioside bands. The plates were photographed with Kodak Technical Pan film. An overlay assay was also used to detect the presence of GM1 on the chromatograms (66.67). HPTLC plates were processed up to the resorcinol step as described above. Chromatograms were then dipped twice in 0.4% polyisobutylmethacrylate (Aldrich Chemicals; Milwaukee, WI) in hexane and air-dried. The chromatograms were then placed in a solution of 2 % bovine serum albumin (BSA) in PBS and swirled on a rotator for 1 hr. The plates were drained, washed three times in PBS for 5 min each, and immersed in a 1: l OOO dilution of an HRP-labeled cholera toxin probe in PBS at room temperature for 1 hr. The chromatograms were rinsed three times in PBS and GM1 bound probe was visualized using DAB Fast tablets (Sigma). The reaction was terminated after approximately 30 sec by washing in distilled water and the plates were air-dried and photographed.
Cholera Toxin B-subunit Probes and Bovine GMl Ganglioside
Three forms of cholera toxin B-subunits were used: unlabeled B-subunit (BCT), B-subunit coupled to F I E (BCT-FITC), and B-subunit coupled to HRP (BCT-HRP). All B-subunit probes were obtained from List Biological Laboratories (Campbell, CA). The lyophilized probes were reconstituted with double-distilled water and stored at 4'C before use. Bovine brain monosialoganglioside-GM1 (Sigma) was reconstituted in PBS to a final concentration of 100 nglml and stored at -75'C before use.
Tissue Fixation, Freezing, Sectioning, and Microscopy
Chinchilla cochleas and small portions of the cerebellum were chemically fived either with a 4% paraformaldehyde solution (pH 7.2) for the FIElabeled probe or with 2.5% glutaraldehyde in 0.1 M phosphate buffer for the HRP-labeled probe. Fixative was introduced into the cochlea either by perilymphatic perfusion (68) or by aortic perfusion. Fixation continued by immersion in the fmuve for 18 hr. Preliminary experiments with Carnoyor ethanol-fixed cochlear tissues indicated no reactivity to the cholera toxin probes. This was presumably due to GM1 attraction by the lipid solvents in these fmtiws. Chemically fmed cochleas were decalcified at 4'C with continuous rotation in 10% EDTA (pH 7.2) for 3 days. After decalcification was complete, cochleas were bisected along a midmodiolar plane with a razor blade and processed as either whole-mount surface preparations of scala media tissues or embedded and xaioned. Whole-mount surface prepantions were processed histochemically and mounted on slides in glycerol containing an anti-fading agent for BC'I-FIE (69). For cryosectioning, each cochlear half was cryoprotected with a sucrose-OCT mixture (70). quick-frozen by immersion in isopentane cooled with liquid nitrogen, and sectioned at 5-7 pm on a Hacker-Bright cryostat. Sectionswere mounted on gelatin-coated glass slida and allowed to dry for 30 min on a slide m e r at 37'C. Slides were nored at -7O'C before W. Tissua wcre enmined using an Olympus Vanox AHBT3 light microscope with brightfield illumination for HRPlabeled tissues and epifluorexence illumination for RTC-labeled tissues. Sections were photographed using Kodak T-Max 800 film push-processed at I S 0 1600.
Histochemistry
Cryoxctions were hydrated by thrce 5-min rinses with PBS. BCT-FIK was applied to the section at dilutions ranging from 1:200-1:5000 in a moist chamber and rotated on an oscillating platform for 30 min. The optimal dilution was determined to be 1:1ooO. The slida were then clcared of unbound probe by five 5-min rinses with PBS and mounted in glycerol as dexribed a k . For the BCT-HRP probe. the cryoxctions were hydrated with PBS and expoxd to the probe at dilutions ranging from 1:500-1:1OOO for 30 min. The slides were rinsed of unbound probe with PBS and the HRP was detected using DAB Fast mcrion (Sigma). The sections were mounted in glycerol and photographed. In addition. unfixed segments of sciatic n e m and organ of Corti were removed from the animals and immerxd in Leibovitr's L15 medium (Gibco; Gnnd Island, NY) containing collagenw Type IV (Sigma) at 1 mglml for 20 min at 4'C to dissociate the n e m fiben and outer hair cells. These unfixed cells were crpoxd to BCT-RTC at a dilution of k500 for 10 min. rinsed with L15. and photographed in vitro.
Controls. Two positive control tissues were uxd. sciatic n e m and cerebellum. GMI has been previously localized using cholera toxin probes in the node of Ranvier in murine sciatic n e m (71.72). and in cerebellum (58).
The pmence of GMI in these tissue was verified using BCT as previously described.
Three negative controls wcre performed ro demonstrate specificity of BCT binding to GMI. As an absorption control, BCT probes were mixed with 100 nglml of bovine GMI at 4'C for 30 min. centrifuged (1300 x GTlb-g for 10 min). and the supematant applied to the tissua. As a masking control, GM1-binding sita in the tima were fim exposure to unlabeled BCT and then to labeled BCT probes. As an extraction control, GMI was removed from tissues by an wending and descending =ria ofethanol concentrations (PBS, 70%. 95%. 100%. 95%. 70%. PBS; 5 min each) before exposure to the BCT probes.
Enzyme Tmunent. To enable better access of the cholera toxin probe to GMI on cells, the glyrocalyx was partially removcd with trypsin. In addition. trypsin degradation was used to remove glycoproteins, if present, that may haw GM1-like carbohydrate-binding sites (73.74). Rehydrated, fixed tissue sections were exposed to trypsin at 37'C for 5 min (Sigma. Type 111 from bovine pancreas) at a concentration of 0.1 mglml in double-distilled wlter containing 0.147 mM CaC12. To convert polysialogangliosida to GMI and to remove terminal sialic acid residues from glycolipids and glycoproteins. tissue xcrions wcre incubated at 37'C with Vibrio cholera ncunminidax (Sigma) at a concentration of 0.6 U in sodium acetate buffer (pH ificity of BCT to GMl and to further identify this ganglioside on the chromatogram, BCT-HRP was reacted with a chromatogram containing ganglioside standards and extracts from cerebellum and inner ear. Only the GM1-containing bands reacted with the BCT probe ( Figure 1B ).
Results
HPTZC
Histochemistry
Positive Control Tissues. Fresh collagenase-dissociated sciatic nerves that were exposed to BCT-FITC or BCT-HRP probes showed intense labeling of the node of Ranvier and the proximal and distal ends of the internodal myelin segments (Figures 2A and 2B ). In addition, thin unmyelinated nerve fibers were also labeled by BCT (not shown). The absorption control showed no reactivity of the probes to the fresh sciatic nerves (not shown). As another positive control, cryosections of paraformaldehyde-fixed cerebellum showed intense reactivity of BCT-FIX and BCT-HRP to molecular, Purkinje, and granular layers of the cerebellum (Figures 2C and  2D) . Absorption, masking, and ethanol-extracted negative controls showed no reactivity to fixed cerebellar sections (not shown). Since our chromatograms and positive and negative control tissues verified the specificity of BCT for GM1 and agree with previously pub-lished results, we will hereafter refer to BCT reactivity as GM1 localization.
Cochlea. In whole-mount surface preparations of cells and tissues of the scala media, GM1 was abundant in many of the epithelial cells. BCT-FITC and BCT-HRP showed similar patterns of reactivity. GM1 appeared abundant in the cell membrane of the interdental cells, inner sulcus cells. inner hair cell stereocilia, inner supporting cells, pillar cells. some outer hair cell stereocilia bundles, Deiters' cells, and Hensen's cells ( Figures 3A-3D ). However, the cuticular plate of the inner and outer hair cells showed little GM1 (Figures 3A, 3B, and 3D ). In addition, the inner hair cell stereocilia were more consistently labeled by BCT than the outer hair cell stereocilia (Figures 3B, 3C, and 3D ). Outer hair cell stereocilia bundle reactivity to BCT was highly variable ( Figures  3B and 3D) . It was clear that the stereocilia of some cells were intensely labeled, whereas those of adjacent cells were weakly labeled ( Figure 3B) .
In radial cryosections of the scala media, GM1 was abundant in the same cells that were labeled by BCT-FITC in the whole-mount surface preparations. GM1 was present in the cell membrane of the interdental cells, inner sulcus cells, inner supporting cells. pil- 
. (A) Surface preparation showing BCT-FITC localization of GM1 in epithelial cells overlying the basilar membrane. Strong reactivity is present in inner sulcus cells (i) and Hensen's (h) cells. (E) Organ of Corti surface preparation showing no reactivity of the hair cell cuticular plate (c) and variable reactivity (arrowheads) of the outer hair cell stereocilia bundles with BCT-FITC. (C) Inner hair cell stereocilia are strongly reactive to BCT-FITC. (D) Organ of Corti showing pillar cells (p) and strong reactivity of the inner and outer hair cell stereocilia bundles (arrows) to BCT-HRP Bars: A
lar cells, Deiters' cells, Hensen's cells, Boettcher's cells, Claudius'
cells, and spiral prominence cells ( Figure 4A ). Less GMl appeared to be present in cells of the stria vascularis, nerve fibers of the osseous spiral lamina, and cells of Reissner's membrane. The mesothelial cells of the basilar membrane, the acellular matrix of the tectorial and basilar membrane, and the matrix and cells of the spiral limbus and spiral ligament contained little GM1. The lateral cell membrane of outer hair cell bodies showed little GM1. However, a nerve fiber that appears to be innervating an outer hair cell high on its cell body did contain GM1 ( Figure 4B ). It could not be determined whether the inner hair cell body contained GM1, as these cells are tightly surrounded by supporting cells that contain abundant GM1. In some cells, such as interdental, pillars, Deiters, and Hensen. GMl appeared to be present both in the membrane and in the cytoplasm (Figures 4A-4C) .
To better define whether the plasmalemma of the outer hair cell body contained GM1, outer hair cells were isolated and stained in vitro with BCT-FITC. Figure 5A shows a brightfield image of an isolated outer hair cell with an attached Deiters' cell. Figure 5B is the same outer hair cell after BCT-FITC exposure and epifluores-cent illumination, showing reactivity at the apex and the base of the cell body. GM1 appeared to be confined to apicolateral and basolateral bands surrounding the cell body. GM1 was also abundant in the Deiters' cell and its processes. BCT labeling of outer hair cell stereocilia was never observed in isolated cells, although stereocilia were present in most isolated cells.
Nerve fibers in the modiolus and the spiral ganglion cells contained less GM1 than the scala media epithelial cells. However, two additional regions of the cochlea appeared to contain abundant GM1: the hemopoietic tissues of the otic capsule and the central part, i.e., past the glial dome, of the VI11 nerve ( Figures 6A and   6B ). GM1 was also abundant in the cochlear nucleus (not shown). Absorption of the BCT-FITC with bovine GMI, ethanol extraction of GM1, and exposure of unlabeled BCT before labeled BCT exposure all produced no reactivity and served as negative controls (not shown).
BCT-HRP revealed a similar but not identical distribution and relative abundance of GM1 in cochlear tissues. In addition, since glutaraldehyde fixation with BCT-HRP could be used and resulted in better tissue preservation, these tissues were used for enzyme degradation experiments. Absorption of BCT-HRP with bovine GM1 produced little reactivity in cochlear tissues ( Figure 7A ). Masking of cochlear GM1 with unlabeled BCT before exposure to BCT-HRP substantially reduced but did not completely abolish BCT-HRP reactivity to GM1 ( Figure 7B ). The DAB reaction on coch-lear tissue not exposed to BCT-HRP showed only reactivity of the endogenous peroxidase of the red blood cells ( Figure 7C ). BCT-HRP ( Figure 7D ) localization of GM1 in cochlear tissue appeared to be more sensitive than BCT-FIE. All of the cells that were reactive to BCT-FIE were more reactive to BCT-HRP. In addition, cells LOCALJZATION OF GM1 GANGLIOSIDE IN THE COCHLEA Masking of tissue GM1 with BCT before BCT-HRP abolished most but not all tissue reactivity. Some reactivity remained in a few scala media epithelial cells (arrowheads). (C) Endogenous peroxidase reactivity is shown in the red blood cells after the DAB reaction (arrow). (D) BCT-HRP localization of GM1 in cochlea appeared more sensitive than BCl-FITC and extended GM1 localization to tissues of the spiral ligament (s) and mesothelial cells of the basilar membrane (arrow) and to some cells in Reissner's membrane (r). (E) Trypsin degradation before BCT-HRP showed increased reactivity to GM1 in all cochlear tissues previously shown to contain GMl. (F) Neuramidase conversion Of polysialogangliosides to GM1 also showed increased reactivity of BCT-HRP to cochlear tissues. A scala tympani region of the spiral ligament (*) showed little GM1 reactivity. Bars = 50 pm. of the spiral ligament and mesothelial cells of the basilar membrane appeared to contain GMl. Tkypsin degradation of cochlear sections resulted in a more intense BCT-HRP reaction in those cells that were positive without trypsin degradation ( Figure 7E ). Neuramidase transformation of polysialogangliosides to GM1 showed increased tissue reactivity by BCT-HRP ( Figure 7F ). However, the primarily connective tissues of the cochleas, including the amorphous layer of the basilar membrane, the tectorial membrane, matrix and cells of the spiral limbus, a scala tympani portion of the spiral ligament, i d the outer hair cell bodies, appeared to contain little GM1 or polysialogangliosides.
Discussion
The present study is the first anatomic description of the distribution of the GM1 ganglioside in cochlea. In addition, this study has corroborated and extended previous biochemical reports of pgliosides in cerebellum and the cochlea (61). With regard to ganglioside distribution in rat and mouse cerebellum, previous reports (63,64,78) agree that the predominate ganglioside is GTlb, followed by GDla and GM1. We observed the same result in chinchilla cerebellum. With regard to ganglioside composition in the inner ear, our results partially agree with those reported by Maguchi and co-workers (61) for rat cochlea. Their results and o m both identified GM3 as the predominate ganglioside in the inner ear. Both studies also agree on the presence of GM1, GD3, GDla, and GTlb in the inner ear. Our study differs from theirs in that we did not find significant GM2 in chinchilla inner ear. However, there are several important methodological differences between the two studies. In addition to a difference in animal species, the two studies differ significantly in the quantity of tissue analyzed, as they used 200 rat cochleas. In addition, different methods were used to separate gangliosides from neutral lipids. Furthermore, they analyzed only the cochlea, whereas we analyzed combined extracts of gangliosides from the cochlea and the vestibular apparatus. However, HPTLC confirmed that GM1 and other gangliosides are present in chinchilla inner ear and that BCT binds specifically and only to the GMl ganglioside in the inner ear.
Additional evidence for the specificity and high affinity of the B-subunit of BCT for GM1 was obtained from our histochemical observations. In the positive controls, the present results agree with reported localization of GMl in cerebellum (58), node of Ranvier, and thin nerve fibers of sciatic nerve (71.72). In addition, the present study verified tissue extraction of GM1 with ethanol (79) , and this property of glycolipids unfortunately prevented us from extending our observations to the electron microscopic level. Furthermore, absorption of BCT with bovine GM1 and masking of GM1 in tissues with unlabeled BCT provided further support for the presence of GM1 in the tissue and the specificity of BCT. Although the present study did not attempt to quantify the amount of GM1 in the inner ear, it appears to be quite abundant. The strength of the histochemical signal from FITC and HRP was very high, considering that GM1 extends only 1 nm above the cell membrane (80) and that each B-pentamer can bind up to five GM1 gangliosides. This suggests that instead of signal amplification, which is commonly employed using indirect immunohistochemistry, these directly labeled histochemical probes may actually represent a fivefold decrease in signal strength. , Although it has been well established that the GM1 ganglioside is the only functional receptor for BCT, GM1-oligosaccharide derivatives have been inserted into cell membranes and have nonfunctionally bound to BCT (81). Therefore, the possibility cannot be exduded that glycoconjugates containing GM1-oligosaccharidetype structures may exist and may bind to the B-subunit of BCT. However, since these carbohydrates are attached to a polypeptide rather than a lipid they would probably be extracted from tissues with trypsin degradation. Our results with trypsin showed an increase rather than a decrease in BCT labeling intensity. This result increases our confidence that BCT is labeling only GM1 in the cochlea. In addition, degradation of glycocalyx glycoproteins by trypsin probably enhanced BCT binding owing to the removal'of steric hindrance by these glycoproteins. Neuramidase transformation of polysialogangliosides to GMl and a corresponding increase in BCT binding confirmed our biochemical findings of other gangliosides in the inner ear.
A substantial glycocalyx on the apical surface of cochlear and vestibular hair cells and supporting cells has been previously described (82-89). However, the composition and function of this specialized cell coat are unknown. Recently, we described the distribution of the GM1 ganglioside in vestibular tissues and showed that it contributed to the glycocalyx of a variety of vestibular cells, including the hair cell stereocilia (59). The present results also have shown the presence of GM1 in many cells lining the scala media, including the hair cell stereocilia. Therefore, GM1 appears to contribute to the glycocalyx of the cochlear hair cell stereocilia, particularly the inner hair cell stereocilia. However, labeling of the cells of Reissner's membrane and the outer hair cell stereocilia was more variable. We also reported this variability in reactivity of certain vestibular supporting cells but not of vestibular hair cell stereocilia, which were always reactive to BCT (59). This variability may be due to differences in expression of GMl by these cells, differences in their glycocalyx that could impair the binding of BCT, or loss of some stereocilia bundles due to binding to the tectorial membrane. Support for glycocalyx hindrance of BCT for GM1 was suggested by the fact that we never observed BCT binding to hair cell stereocilia in vitro.
Although gangliosides have been reported to occur on the apical surface of polarized cells (66,90), the present results have shown that they also occur on the basolateral surface of most polarized epithelial cells of the scala media. Furthermore, GMI appears to be intracellularly distributed in the interdental, Deiters', pillar, and Hensen's cells. Intracellular distribution of gangliosides, which is thought to be related to ganglioside synthesis, has also been reported for other cell types (91,92). In the outer hair cells, two bands of GM1-enriched membrane were observed at the apical and basal ends of the cells. We interpret this to be due to membrane frag ments of Deiters' cell processes, since these regions are attachment points for the GM1-enriched Deiters' cell processes to the outer hair cell body. Therefore, GMI appears to be enriched only in the hair cell stereocilia, or its identification may be impaired by a basolateral hair cell glycocalyx. The distribution of GM1 in the outer hair cell plasmalemma is interesting and should be further investigated.
The holotoxin of cholera toxin has been injected into the scala media of the cochlea to stimulate adenylate cyclase and determine the role of this enzyme in endolymph production (93). Feldman and Brusilow (93) found a significant increase in inulin dilution 72 min after cholera toxin administration and suggested that it reflected an increase in endolymph volume. The highest concentration of adenylate cyclase has been localized to the basolateral membranes of the marginal cells of the stria vascularis and to the endolymphatic surface of Reissner's membrane (94,95) . Although our results demonstrate the presence of GM1 in these cells, this study has demonstrated that GMI also occurs in other cochlear cells.
The distribution and function of gangliosides in the inner ear are poorly understood. However, a better understanding of these macromolecules may provide important insights into the membrane properties of the cells of the inner ear. Although neuroprotection against trauma by gangliosides has been well documented in the CNS, only a few experiments (20) (21) (22) have explored this property of gangliosides in the inner ear. Furthermore, the presence of antiganglioside antibodies in patients with motor neuropathies and inner ear dysfunction may provide clues to the function of these macromolecules in the inner ear. 40.
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